Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04855825 · ClinicalTrials.gov registry record · NA

Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

A NA study of Multiple Sclerosis and Cognitive Impairment, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04855825: Recruiting NA study of Multiple Sclerosis and Cognitive Impairment, sponsored by Kessler Foundation.

NCT04855825 is a NA study of Multiple Sclerosis and Cognitive Impairment that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 10 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04855825, a NA study of Multiple Sclerosis and Cognitive Impairment, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking abilities of individuals with multiple sclerosis who went through the traditional as compared to others who used the robotic exoskeleton as part of their therapy.

Primary Outcome

The distance walked (meters) in 6 minutes is measured. This is following the 6-minute walk test (6MWT) procedure to measure walking endurance. The 6MWT is is a valid and reliable test of endurance walking performance in persons with MS. Participants are instructed to walk as fast and as far as possible for 6 minutes within a single corridor and performing 180° turns.

Interventions

  • DEVICE Robotic Exoskeleton Rehabilitation
  • OTHER Conventional Gait Therapy

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-10-05
Est. Completion 2027-12-30
Phase NA
Kessler Foundation

104 total trials

What NCT04855825 shows while recruiting

NCT04855825 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower).

The record links to 4 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Robotic Exoskeleton Rehabilitation is the first listed.

NCT04855825 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT04855825 about?

NCT04855825 is a clinical study titled "Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS". The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking a...

What is the current status of trial NCT04855825?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2017-10-05. Estimated completion is 2027-12-30.

What conditions does trial NCT04855825 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Cognitive Impairment, Gait Disorders, Neurologic, Motility Disorder.

What interventions are being tested in trial NCT04855825?

The interventions under investigation include: Robotic Exoskeleton Rehabilitation (DEVICE), Conventional Gait Therapy (OTHER).

Who is sponsoring clinical trial NCT04855825?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04855825 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04855825's enrollment target sits among peer trials

10 305th of 315 higher than 9 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04855825, the US trial registry maintained by the National Library of Medicine. NCT04855825 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.